citalopram has been researched along with Bulimia Nervosa in 1 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Bulimia Nervosa: An eating disorder that is characterized by a cycle of binge eating (BULIMIA or bingeing) followed by inappropriate acts (purging) to avert weight gain. Purging methods often include self-induced VOMITING, use of LAXATIVES or DIURETICS, excessive exercise, and FASTING.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to evaluate the efficacy and safety of high-dose escitalopram in the treatment of binge-eating disorder (BED) associated with obesity." | 9.13 | High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial. ( Alessio, DD; Guerdjikova, AI; Hudson, JI; Keck, PE; Kotwal, R; Lake, K; McElroy, SL; Nelson, E; Welge, JA, 2008) |
| "The purpose of this study was to evaluate the efficacy and safety of high-dose escitalopram in the treatment of binge-eating disorder (BED) associated with obesity." | 5.13 | High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial. ( Alessio, DD; Guerdjikova, AI; Hudson, JI; Keck, PE; Kotwal, R; Lake, K; McElroy, SL; Nelson, E; Welge, JA, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guerdjikova, AI | 1 |
| McElroy, SL | 1 |
| Kotwal, R | 1 |
| Welge, JA | 1 |
| Nelson, E | 1 |
| Lake, K | 1 |
| Alessio, DD | 1 |
| Keck, PE | 1 |
| Hudson, JI | 1 |
1 trial available for citalopram and Bulimia Nervosa
| Article | Year |
|---|---|
High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial.
Topics: Adolescent; Adult; Bulimia Nervosa; Citalopram; Dose-Response Relationship, Drug; Double-Blind Metho | 2008 |